Valuation: DiaSorin S.p.A.

Market Cap 3.62B 4.13B 3.34B 3.13B 5.86B 390B 5.98B 40.13B 15.53B 193B 15.51B 15.17B 668B P/E 2026 *
19.9x
P/E 2027 * 17.4x
Enterprise Value 4.3B 4.9B 3.96B 3.71B 6.95B 462B 7.1B 47.6B 18.42B 228B 18.4B 18B 792B EV / Sales 2026 *
3.5x
EV / Sales 2027 * 3.19x
Free-Float
-
Yield 2026 *
1.91%
Yield 2027 * 1.99%
1 day+2.92%
1 week+5.04%
Current month+2.74%
1 month+4.34%
3 months+17.30%
6 months+2.58%
Current year-0.41%
1 week 64.46
Extreme 64.46
68.48
1 month 62.96
Extreme 62.96
75.3
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 2007-03-25
Director of Finance/CFO - 2024-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 2016-04-27
Director/Board Member 63 2007-03-25
Chairman 57 2022-04-28
Date Insider Type Main position Quantity % Market Cap.
03-23Buy

Chief Executive Officer

9,211 0.0165%
01-27Buy

Chief Executive Officer

7,500 0.0134%
01-07Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
+2.92%+5.04%-25.75%-25.00% 4.13B
+4.39%+13.23%+193.39%+304.83% 19.79B
+1.64%+3.26%-40.13%-22.35% 9.59B
+0.72%+5.72%+34.74%+30.03% 7.15B
-1.07%+0.16%-31.00% - 5.23B
-0.45%+0.93%-24.29%-28.99% 4.9B
+2.85%+5.74%+213.30%-32.69% 4.67B
-7.42%-9.54%+84.72%+88.33% 4.09B
-2.97%-5.81%-23.11%-45.30% 2.41B
+0.11%-1.54%-36.46%-55.18% 1.25B
Average +0.07%+1.77%+34.54%+23.74% 6.32B
Weighted average by Cap. +1.39%+5.25%+71.89%+100.36%

Financials

2026 *2027 *
Net sales 1.23B 1.4B 1.13B 1.06B 1.99B 132B 2.03B 13.59B 5.26B 65.23B 5.25B 5.14B 226B 1.31B 1.49B 1.2B 1.13B 2.11B 141B 2.16B 14.48B 5.6B 69.47B 5.6B 5.47B 241B
Net income 182M 207M 167M 157M 294M 19.53B 300M 2.01B 778M 9.65B 778M 761M 33.47B 205M 234M 189M 177M 333M 22.11B 339M 2.28B 881M 10.93B 880M 861M 37.89B
Net Debt 674M 769M 621M 582M 1.09B 72.52B 1.11B 7.47B 2.89B 35.84B 2.89B 2.82B 124B 543M 619M 501M 469M 879M 58.42B 897M 6.02B 2.33B 28.87B 2.33B 2.27B 100B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,242
Date Price Change Volume
26-06-26 €68.34 +2.92% 208,577
26-06-25 €66.40 -0.12% 239,419
26-06-24 €66.48 +3.13% 223,750
26-06-23 €64.46 -1.53% 212,056
26-06-22 €65.46 +0.61% 142,958
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
68.34EUR
Average target price
70.52EUR
Spread / Average Target
+3.19%

Quarterly revenue - Rate of surprise